Wealthsource Partners LLC bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 9,294 shares of the company’s stock, valued at approximately $303,000.
Other hedge funds have also recently bought and sold shares of the company. IFP Advisors Inc grew its holdings in Bath & Body Works by 23.7% during the third quarter. IFP Advisors Inc now owns 6,150 shares of the company’s stock worth $382,000 after acquiring an additional 1,177 shares during the period. SG Americas Securities LLC grew its holdings in Bath & Body Works by 193.8% during the third quarter. SG Americas Securities LLC now owns 22,426 shares of the company’s stock worth $731,000 after acquiring an additional 14,793 shares during the period. CoreCap Advisors LLC acquired a new position in Bath & Body Works during the second quarter worth about $39,000. Mane Global Capital Management LP acquired a new position in Bath & Body Works during the third quarter worth about $18,433,000. Finally, Canada Pension Plan Investment Board grew its holdings in Bath & Body Works by 15.4% during the third quarter. Canada Pension Plan Investment Board now owns 27,710 shares of the company’s stock worth $903,000 after acquiring an additional 3,700 shares during the period. 96.34% of the stock is owned by institutional investors and hedge funds.
Bath & Body Works Price Performance
Shares of Bath & Body Works stock opened at $35.95 on Wednesday. The firm has a market cap of $8.21 billion, a price-to-earnings ratio of 10.42, a P/E/G ratio of 1.01 and a beta of 1.77. Bath & Body Works, Inc. has a 52-week low of $25.75 and a 52-week high of $58.17. The stock has a 50-day simple moving average of $43.71 and a 200-day simple moving average of $39.62.
Bath & Body Works Dividend Announcement
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on BBWI. Barclays lifted their price target on Bath & Body Works from $39.00 to $43.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 22nd. Cowen lifted their price target on Bath & Body Works from $45.00 to $52.00 and gave the stock an “outperform” rating in a research note on Thursday, February 16th. Telsey Advisory Group reissued an “outperform” rating and issued a $52.00 price target on shares of Bath & Body Works in a research note on Thursday, February 23rd. Piper Sandler lifted their price target on Bath & Body Works from $50.00 to $52.00 in a research note on Tuesday, January 3rd. Finally, Raymond James dropped their price target on Bath & Body Works from $52.00 to $50.00 and set a “strong-buy” rating on the stock in a research note on Friday, February 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $49.52.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
- Get a free copy of the StockNews.com research report on Bath & Body Works (BBWI)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts DefendĀ
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Get Rating).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.